FDA's Pulmonary-Allergy Drugs Advisory Committee to Review Proposed Changes to Asthma and Allergy Medication Guidance

Summary

The Pulmonary-Allergy Drugs Advisory Committee will examine proposed updates to the FDA's guidance on asthma and allergy medications, following a request from the agency to review the existing notice.